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ABSTRACT
Optical DNA mapping (ODM) allows visualization of
long-range sequence information along single DNA
molecules. The data can for example be used for
detecting long range structural variations, for aid-
ing DNA sequence assembly of complex genomes
and for mapping epigenetic marks and DNA dam-
age across the genome. ODM traditionally utilizes
sequence specific marks based on nicking enzymes,
combined with a DNA stain, YOYO-1, for detection
of the DNA contour. Here we use a competitive bind-
ing approach, based on YOYO-1 and netropsin, which
highlights the contour of the DNA molecules, while
simultaneously creating a continuous sequence spe-
cific pattern, based on the AT/GC variation along
the detected molecule. We demonstrate and validate
competitive-binding-based ODM using bacterial arti-
ficial chromosomes (BACs) derived from the human
genome and then turn to DNA extracted from white
blood cells. We generalize our findings with in-silico
simulations that show that we can map a vast ma-
jority of the human genome. Finally, we demonstrate
the possibility of combining competitive binding with
enzymatic labeling by mapping DNA damage sites in-
duced by the cytotoxic drug etoposide to the human
genome. Overall, we demonstrate that competitive-
binding-based ODM has the potential to be used
both as a standalone assay for studies of the human
genome, as well as in combination with enzymatic
approaches, some of which are already commercial-
ized.
INTRODUCTION
Optical DNA mapping (ODM) is based on visualizing the
sequence of ultralong DNA molecules (>100 000 basepairs
(bp)), covering length scales on DNA that are not accessi-
ble with modern sequencing techniques (1). This opens up
the possibility to identify large structural variations (2–11),
as well as to use optical maps as scaffolds to organize se-
quencing contigs along complex genomes (12–15). Optical
maps are created by labeling individual DNA molecules in
a sequence-specific manner, stretching the molecules, and
imaging them using a fluorescence microscope (16). The
stretching is done either on a glass surface (17–19) or in
nanofluidic channels (16,20–22), where the latter allows
for more uniform stretching while still permitting high-
throughput analysis.
Most examples of ODM in the literature are based on en-
zymatic labeling, as pioneered by Schwartz and colleagues
(23). At present, nicking enzymes are most widely used,
which create a nick in the DNA backbone at a specific (7
bp) sequence (13,24,25). The nick is then repaired with a
polymerase and a ligase in presence of fluorescently labelled
nucleotides. The result is an array of sequence-specific ‘dots’
along DNA that can for example be matched to a genome of
interest to find structural variations (2,3), or used for de novo
assembly of complex genomes (12,26,27). Issues with nick-
labeling include <100% labeling efficiency and that nicking
makes the DNA more fragile, where two nicks occurring too
close together on opposite strands of the DNA will cause a
double strand break, leading to shorter DNA molecules and
loss of information. Also, regions without any recognition
sites remain uncharacterized. Recently, enzymatic labeling
with methyltransferases was introduced (28,29). This strat-
egy positions labels on DNA without damaging the DNA,
which opens up the possibility for denser labeling.
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Enzymatic assays can also be used to label other fea-
tures along the DNA. Examples include the epigenetic
marks methylation (30,31) and hydroxymethylation (32,33),
as well as DNA damage (34). By labeling the DNA with
multiple colors, it is possible to combine sequence specific
labels with epigenetic DNA marks, which makes it possible
to, for example, locate hydroxymethylations along the hu-
man genome (33).
We have developed an ODM assay based on the binding
of two small molecules, YOYO-1 and netropsin, to DNA.
Netropsin blocks AT-rich regions from binding of the fluo-
rescent, nonspecific, YOYO-1, which leads to that AT-rich
regions are darker than GC-rich regions (Figure 1) (35). We
have previously used this competitive binding-based assay
for studies on bacterial DNA (36), and in particular bac-
terial plasmids (37–42). The principle is the same as the
melt mapping assay initially proposed by Reisner et al. (43),
where DNA is stained with YOYO-1 and partially melted.
Melt mapping has been used on the human DNA in several
studies (44–46) where very long DNA molecules (>1 mega
base pair (Mb)) are stretched one by one in two counter
propagating flows. This principle requires extensive hands
on manipulation and is not suited for high-throughput ap-
plications.
All the enzymatic labeling protocols require extensive
sample preparation with, among other things, several wash-
ing steps to remove unbound fluorescent dyes. The com-
petitive binding-based method, on the other hand, requires
only one step of simultaneous addition of YOYO-1 and
netropsin to DNA. No additional step to remove excess
YOYO-1 is necessary since YOYO-1 is only fluorescent
when bound to DNA (47). Furthermore, in most enzymatic
labeling protocols, YOYO-1 is added to visualize the DNA
backbone and to estimate the length of each fragment. Us-
ing the competitive binding assay, the images of YOYO-1
labeled DNA will also provide sequence information and
the possibility to locate a specific fragment along the hu-
man genome, without increasing the demands on the opti-
cal setup. A final benefit with the affinity-based approaches
is that they do not depend on the presence of specific en-
zymatic sites along the DNA, instead providing continuous
sequence information along the DNA.
In this study we have, for the first time, applied com-
petitive binding-based ODM to human DNA, focusing on
investigating the possibilities for future high-throughput
analysis. We establish the basic principles using bacterial
artificial chromosomes (BACs, 123–203 kilobases (kb) in
size) and later turn to DNA extracted from peripheral blood
mononuclear cells (PBMCs), where we show that we can
map long DNA molecules (∼200–600 kb) to the human
genome with high precision. We generalize our findings in
silico by showing that we can in theory cover 97% of the
human genome with a fragment size of 333 kb. Finally, we
demonstrate the possibility of combining competitive bind-
ing with enzymatic labelling by locating DNA damage sites
induced by the cytotoxic drug etoposide in human PBMCs
along the genome. The latter is, to our knowledge, the first
demonstration of combining affinity-based and enzymatic
labeling in ODM.
MATERIALS AND METHODS
Samples and DNA extraction
Bacterial Artificial Chromosomes (BACs) were used to op-
timize the experimental settings and the P-value threshold
(37,39). For details about the five BACs used in the study,
see Supplementary Table S1. The circular BACs were lin-
earized using the restriction enzyme NotI to remove the
cloning vector. To that end, 600 ng BAC was incubated with
20 U of restriction enzyme (NotI-HF, New England Bio-
Labs) at 37◦C for 1 h in 1× CutSmart Buffer (New England
BioLabs) with a total volume of 20 l. The reaction was
terminated by heat deactivation at 65◦C for 20 min.
Human DNA was extracted from excess blood with
healthy blood counts, obtained from the Hematology unit
at the Clinical Chemistry Department at Sahlgrenska
University Hospital, Sweden. Peripheral blood mononu-
clear cells (PBMCs) were isolated from the blood samples
through gradient centrifugation using Lymphoprep (Axis-
Shield PoC AS) according to the manufacturer’s instruc-
tions. The harvested cells were resuspended in Cell Suspen-
sion Buffer from the CHEF Mammalian Genomic DNA
Plug Kit (BIO-RAD). The cell suspension was mixed with
2% CleanCut Agarose (BIO-RAD) to obtain a final con-
centration of 0.75% agarose and the mixture was left for
solidification in 100 l plug molds at 4◦C for 15 min. The
solidified agarose plugs were incubated with Proteinase K
overnight at 50◦C according to the BIO-RAD protocol.
Next, the plugs were washed four times in 1× Wash Buffer
(BIO-RAD) for 1 h at room temperature with gentle agita-
tion. The plugs were further washed in 1 mM phenylmethyl-
sulfonyl fluoride followed by a final wash with 0.5× Wash
Buffer. The agarose plugs were digested by first melting the
plugs at 70◦C for 10 min, followed by incubation with 0.5
U of Agarase (Thermo Fisher Scientific) at 42◦C for 1 h.
The DNA concentration was determined using a Nanodrop
1000 (Thermo Scientific).
For DNA damage experiments, the PBMCs were treated
with the topoisomerase II inhibitor etoposide. In brief, 100
mM stock solutions of etoposide (Sigma) were prepared in
DMSO and stored at −80◦C. The cells were resuspended in
RPMI medium 1640 at 4 × 106/0.5 ml and incubated with
37.5 M etoposide under dark conditions at 37◦C for 2 h.
The cells were washed by addition of 1× PBS containing
0.01% bovine serum albumin and centrifugation at 200 g
for 2 min at 4◦C and the supernatant was discarded. The
washing step was repeated twice. DNA extraction was then
carried out as described above.
DNA labeling
The sequence specific DNA barcode was obtained by
a single-step staining reaction using YOYO-1 (ex. 491
nm/em. 509 nm, Invitrogen) and netropsin (Sigma-Aldrich)
(35). The DNA was incubated at 50◦C for 30 min in a 10
l solution containing 1 M DNA sample, 1 M -DNA
(used as internal size reference, 48 502 bp, Roche Biochem
Reagents), 0.2 M YOYO-1 and 60 M netropsin in 0.5×
TBE (Tris-Borate-EDTA, Medicago) resulting in molar ra-
tios of 1:10 (YOYO-1: DNA base pair) and 1:300 (YOYO-
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Figure 1. Schematic overview of the optical DNA mapping assay. Large DNA fragments are extracted from the cells of interest prior to the one step
labeling of the DNA with YOYO-1 and netropsin. The DNA is then stretched in nanofluidic channels and imaged using a fluorescence microscope. Prior
to creating the affinity-based barcode with YOYO-1 and netropsin, there is a possibility to pre-label the DNA with either epigenetic, sequence, or damage
specific fluorescent marks. The obtained data can be used for multiple applications, such as diagnostics of genetic diseases, detection of structural variations
(SV), de novo assembly of complex genomes and/or detection of other genetic or epigenetic marks.
1: Netropsin). The solution was then diluted ten times with
88 l ultrapure water and 2 l -mercaptoethanol (BME,
Sigma-Aldrich), to a final buffer concentration of 0.05×
TBE. BME was used to suppress photodamage to the sam-
ple.
For DNA extracted from cells treated with etoposide,
DNA damage sites were labeled prior to staining the DNA
with YOYO-1 and netropsin. The labeling reaction, adapted
form Zirkin et al. (34), was performed using 500 ng of DNA,
10 U DNA Pol 1, 100 M of dATP, dGTP, dCTP, 10 M
dTTP and 10 M Aminoallyl-dUTP-ATTO-647N (ex. 643
nm/em. 665 nm, Jena Bioscience), in 1× nick translation
buffer (0.05 M Tris–HCl pH 7.2, 0.1 mM dithiothreitol, 0.01
M MgSO4, 50 g/ml BSA) in a final volume of 100 l. The
incubation was done overnight at 16◦C and the reaction was
terminated with 2.5 l of 0.25 M EDTA.
Nanofluidic experiments
Nanofluidic devices were fabricated in silica using standard
methods, as described elsewhere (20). The device consists
of two pairs of loading wells, each pair connected via a
microchannel. The two separate microchannels are in turn
connected by 120 nanochannels with dimensions of 100 ×
150 nm2 and a length of 500 m. The chips were pre-wetted
with 0.05× TBE buffer (2% BME v/v) to achieve uniform
conditions prior to sample loading. A sample volume of
10 l was added to one of the loading wells on the chip
and buffer in the others and the DNA was loaded into the
nanochannels using pressure driven N2 flow.
Imaging was performed using an inverted fluorescence
microscope (Zeiss AxioObserver.Z1) equipped with a 63×
(1.6× optovar) oil immersion objective (NA = 1.46, Zeiss),
a Colibri 7 light source (Zeiss) and an Andor iXon EM-
CCD Camera. In total, a series of up to 100 images were ac-
quired for each molecule using an exposure time of 100 ms
and a FITC filter set (Zeiss). For the dual channel imaging
of etoposide damaged DNA, a total of 20 frames were ac-
quired in each channel, using 1× optovar and a dual band-
pass 90 HE filter set (Zeiss).
Data analysis
The data analysis for mapping individual DNA molecules
to the human genome was performed using application spe-
cific Matlab code, for details see Supplementary Methods.
In short, DNA molecules are individually detected from
each time frame and stacked as kymographs, where each
row represents the intensity along the DNA molecule in
one single frame. The features in the kymographs are then
aligned to compensate for the small thermal fluctuations of
the DNA inside the nanochannels. When only a single time
frame was used, no alignment was done. Next, the aligned
kymographs are collapsed, rendering a time averaged 1D in-
tensity trace along the extension of the DNA molecule, re-
ferred to as a barcode, that can be compared to the theoret-
ical barcode of the human genome. For the initial compar-
isons of the BACs with the human genome, averaged experi-
mental barcodes (consensus barcodes) from multiple copies
of the same BACs were used (38).
To compare an experimental barcode to the human
genome, theoretical barcodes based on the base pair se-
quence of all 24 chromosomes (GRCh38.p7 dataset, re-
trieved from NCBI) were generated, using previously estab-
lished methods (36,37). In short, the theoretical barcode is
estimated based on sequence-dependent binding constants
of netropsin, a sequence-independent binding constant of
YOYO-1, and the point-spread function of the microscope.
We do not take the minor variations in the physical proper-
ties of DNA, such as the small sequence dependence of the
persistence length (48), or effects of YOYO-1 binding (49),
into account. The theoretical barcode was adjusted based
on the degree of DNA extension for each experiment, i.e. the
number of base pairs per pixel, that was determined using
the internal size reference -DNA (48 502 bp), or directly
calculated based on the size of a known BAC sequence. The
best fit to the human genome was assessed using a match
score, based on a Pearson correlation coefficient (C), evalu-
ating each possible start position (pixel), for both the orig-
inal, as well as the flipped, version of the experimental bar-
code, compared to the theoretical human genome, where the
highest match score (Cmax) corresponds to the best fit. In
the case of the BACs, for which the correct positions on the
theoretically generated human genome were known, all ex-
perimental barcodes with Cmax within a range of 20 pixels
(2 × 10−7 fraction of human genome) were classified as be-
ing correctly placed.
For the experiments where DNA damage sites were visu-
alized at the same time as obtaining the sequence specific
barcode, the images obtained from the ATTO-647 channel
were processed separately. Prior to extracting the intensity
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trace along the extension of the DNA molecule, retrieved
from the YOYO-1 channel, the raw stack of images from
the ATTO-647 channel of each individual DNA molecule
was averaged. The intensity trace along the region of in-
terest (ROI) was extracted by averaging over 5 pixels. The
background was then removed by applying a Gaussian fil-
ter (with standard deviation of 8 pixels) and subtracting
the intensity obtained when averaging over 5 pixels above
the ROI. Finally, the background corrected intensity trace
was normalized.
RESULTS AND DISCUSSION
In this study we demonstrate how optical DNA maps, i.e.
barcodes, obtained via a single-step competitive binding
assay, can be mapped with high precision to the human
genome. A schematic representation of the assay is shown in
Figure 1. The barcode is created by simultaneously adding
YOYO-1 and netropsin to DNA (35). In a typical experi-
ment ∼500 pg of DNA is loaded into a nanofluidic chip.
By stretching the DNA molecules in nanochannels, the se-
quence specific barcode is read using a fluorescence micro-
scope (see Materials and Methods for details). We optimize
the assay on BACs of known sequence, before applying it
on human DNA extracted from blood samples, including
experiments were the barcode is combined with enzymatic
labeling of DNA damage.
Evaluation and optimization of performance using bacterial
artificial chromosomes
Five different BACs were used to assess the potential of the
assay, as well as to optimize the experimental and compu-
tational parameters. As a first evaluation of applying com-
petitive binding based ODM on the human genome, mul-
tiple copies (see Supplementary Table S1 for details) of ex-
perimental barcodes (each consisting of 10 frames) for each
BAC were averaged in order to maximize the signal to noise
ratio (SNR) of the experimental data (38). The averaged ex-
perimental barcodes were then scanned against a theoret-
ically generated barcode of the entire human genome (see
Methods), based on the base pair sequence (36,37), in or-
der to find the position of the best fit (Figure 2).
The averaged experimental barcodes for all five BACs ob-
tain the highest Cmax to the correct position of the human
genome and display an excellent overlap between the ex-
perimental and theoretical barcode, demonstrating the high
discriminatory power of the barcodes. However, when ap-
plying the assay to the entire human genome, it will not
be possible to average multiple experimental barcodes in
order to increase the SNR, due to random fragmentation
of the DNA. Also, to optimize the throughput of the as-
say, the number of time frames acquired for each individual
molecule should be minimized.
The number of frames acquired for each individual
molecule will affect both the throughput, increasing with
decreasing number of frames, as well as the accuracy, in-
creasing with increasing number of frames. To investigate
the relation between the accuracy (quantified by Cmax) and
the number of time frames used, multiple experimental bar-
codes for each of the five BACs were compared to their cor-
responding theoretical barcode, varying the number of time
Figure 2. Fits of averaged experimental BAC barcodes to the human
genome. Each averaged experimental BAC barcode is shown at the posi-
tion of the best obtained fit along the human genome. The text in each plot
displays BAC name followed by chromosome number as well as position
along that chromosome.
frames. The results (Supplementary Figure S1A) show how
Cmax increases with increasing number of frames. Supple-
mentary Figure S1B demonstrates how the noise is reduced
when averaging multiple time frames, increasing the simi-
larity with the theoretical barcode as the number of time
frames increases. For the experiments below, the number of
frames was fixed to ten, where ∼96% of the maximal Cmax
was obtained. It should be noted that even with a single time
frame, the average Cmax is still as high as 83% of its max-
imal value. Hence, depending on application, the optimal
number of time frames will vary, balancing throughput and
accuracy.
When an experimental barcode is compared to the the-
oretical barcode of the human genome, the number of bp
per pixel, reflecting the degree of DNA extension in the
nanofluidic channels, is needed. We use -DNA as an inter-
nal size reference to convert between pixels and base-pairs
to minimize the error due to variations in DNA stretching
between different experiments. Due to experimental uncer-
tainties, there is however still a need to account for small
variations in the extension of the DNA to make sure that
as many of the experimental barcodes as possible find their
correct position on the human genome. Increasing the al-
lowed size variation will increase the probability of fitting to
the correct position on the human genome, but at the same
time increases the ‘risk’ of the experimental barcode fitting
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Figure 3. Evaluation of P-value threshold using BACs. Remaining
molecules (yellow) after applying different P-value thresholds, and frac-
tion of false positives (green), of experimental barcodes from BACs when
mapped to the human genome. Blue line is fraction of correctly placed
experimental barcodes out of the remaining (yellow) molecules at each P-
value threshold. All barcodes (N = 187) were compared using 10 frames
and up to 5% stretch (1% steps).
well to other regions of the human genome. Experimental
barcodes of the five different BACs, all consisting of ten
frames, were compared to the human genome with different
size variations allowed (Supplementary Figure S2). The op-
timal amount of stretching for the five examined BACs was
always between 2 and 10%, with an overall optimal value of
5%.
Establishment of a P-value threshold
When comparing the experimental fragments to the human
genome it is important to distinguish correctly placed bar-
codes from false positives. To eliminate false positives, a
P-value was introduced, based on the obtained Cmax score
and the size of each individual fragment (see Supplemen-
tary Methods for details). The effect of decreasing P-value
thresholds on the number of false positives can be seen in
Figure 3, and examples of fits of individual BAC molecules
to their correct positions in the human genome in Supple-
mentary Figure S3.
As expected, the number of molecules passing the P-value
threshold decreases with a decreasing P-value threshold,
with below 20% left at P = 10−6 (Figure 3). However, as
the P-value threshold was decreased to 10−6, false positives
were completely eliminated, and hence only barcodes that
match to the correct position along the human genome re-
mained. The need for a lower P-value threshold compared
to our previous studies (37,38), can to some extent be ex-
plained by the sequence similarities found in the human
genome, that leads to that experimental barcodes match
with a high score (Cmax) not only to one position, but rather
two or more. This is not the case for the randomized refer-
ence barcodes used to generate the P-values. Therefore, a
very low threshold is necessary to make sure that the bar-
codes indeed fit only to the correct position. The P-value is
very sensitive to the size of the experimental fragments. For
the largest BAC, J21 (203 kb), 53% of the data passed the P-
value threshold of 10−6 compared to only 11% for the small-
est BAC P18 (123 kb). A longer fragment contains more
information, and the number of highly similar sequences
in the human genome will decrease rapidly with increasing
size. Since Cmax for a match between an experimental and
theoretical barcode is not sensitive to size, mapping longer
DNA molecules will make it possible to use a significantly
larger fraction of the data at P = 10−6, than for the shorter
BAC molecules.
Mapping DNA extracted from blood samples
To evaluate the applicability of matching any DNA frag-
ments to the human genome, DNA was extracted from
PBMCs. The DNA extraction was performed in agarose
plugs to obtain long (>200 kb) DNA molecules (see Meth-
ods for details). All experimental barcodes (each consisting
of 10 frames) were mapped to the human genome, using a
P-value threshold of 10−6. Examples of fits between experi-
mental barcodes and the human genome reference barcode
are shown in Figure 4.
The experimental and theoretical barcodes showed ex-
cellent overlap to the identified location within the human
genome, all with P-values well below 10−6. For the barcode
in Figure 4C, a highly repetitive region was observed (light
gray area, details in Supplementary Figure S4). The repeats
(Figure 4E) correspond to the GC rich exons of the Proto-
cadherin Alpha gene cluster which is composed of 15 cad-
herin superfamily genes related to the mouse CNR genes.
These neural cadherin-like cell adhesion proteins are inte-
gral plasma membrane proteins that most likely play a crit-
ical role in the establishment and function of specific cell-
cell connections in the brain (50,51). The observation of this
repetitive region highlights the ability of ODM to acquire
long range sequence information, which is a great advan-
tage compared to traditional sequencing techniques. Using
ODM, repeats can be quantified directly from the barcode,
and variations between different cells identified, informa-
tion which is likely to be averaged out when using DNA se-
quencing alone.
In total, 95% (36/38) of the DNA molecules collected
(215–439 kb in size, average 333 kb) passed the P-value
threshold of 10−6, compared to 16% (30/187) for the BACs.
As expected, the longer DNA fragments extracted from the
PBMCs increases the ‘uniqueness’ of the barcode and hence
a highly reliable fit can be obtained for a vast majority of the
experimental fragments. It should be noted that even when
the number of time frames was reduced from ten to a sin-
gle snapshot, the number of molecules that fit to the human
genome with a P-value below 10−6 was still as high as 79%
(30/38), which further demonstrates the potential of com-
petitive binding-based ODM for high-throughput applica-
tions. Moreover, the throughput of the ODM assay will also
depend on the combination of exposure time and light in-
tensity (Supplementary Figure S5).
The data presented in Figure 4 represents only a small
fraction of the human genome. To generalize our results, we
performed in silico simulations to, i) evaluate the impact of
fragment size on the P-value, and ii) assess which parts of
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Figure 4. Fits of experimental barcodes of single DNA molecules to the human genome. Four examples (A–D) of experimental barcodes mapped to
the human genome (10 frames, 5% stretch, 1% steps). The light gray area in (C) highlights a repetitive sequence which is shown in more detail in (E).
The approximate positions of the fits for all DNA molecules passing the P-value threshold (P < 10−6) are shown as dark gray lines (colored lines mark
positions for barcodes shown in the figure) on a schematic illustration of the human genome (center). (E) RefSeq genes (blue) and GC content (black) for
the repetitive region found in (C). The GC sequence content is displayed with a 5bp window.
the human genome that can be mapped using the compet-
itive binding assay. The results (Supplementary Figure S6)
predict that it should be possible to obtain a P-value below
our threshold of 10−6 for all DNA-molecules larger than ap-
proximately 275 kb, and in many cases for fragments down
to 100 kb.
For the evaluation of mappable regions in the human
genome, simulations were made based on the average size
(333 kb) and the average Cmax (≈0.81) of the mapped DNA-
molecules from Figure 4 (details in Supplementary Meth-
ods). In short, the human genome was randomly cut into
333 kb fragments, which were then compared to the com-
plete human genome. All fragments which obtained a Cmax
greater than 0.81, excluding the Cmax to the original posi-
tion of each fragment, are considered to be non-mappable,
due to the lack of uniqueness in the barcode compared to
the human genome.
The results from the simulation (Figure 5) demonstrate
that it is possible to map 97% of the human genome with 333
kb DNA molecules, further demonstrating the potential of
competitive binding based ODM. The remaining 3%, which
are deemed ‘non-mappable’ using a fragment size of 333 kb,
represents parts of the human genome that are too simi-
lar to be separated via the optical maps. However, even if
fragments originating from these regions cannot be exactly
placed, the correct position could in many cases be nar-
rowed down to just a few alternatives (see Supplementary
Figure S7). Moreover, restricted by the field of view, we are
not able to map the largest DNA fragments from the DNA
extraction. Using a meandering nanochannel (52) would al-
low fragments larger than 600 kb in size to be mapped which
would mean that the percentage of mappable regions would
increase even further. Additionally, with increasing size of
the DNA fragments the ability to detect differences over
highly variable regions will increase, where one part of the
DNA molecule can be used to find a match with a high de-
gree of confidence, while the other part can reveal structural
variations.
Dual labeling for extracting information beyond the DNA se-
quence
An attractive potential use of competitive binding based
ODM is to map other types of information, such as epi-
genetic marks and DNA damage lesions, to the human
genome. As a proof of principle, damage sites in DNA from
PBMCs exposed to the chemotherapeutic agent etoposide
were labeled in vitro, prior to adding YOYO-1 and netropsin
to create the sequence specific barcode (see Methods for de-
tails). The damage sites were visualized with fluorescently
labeled nucleotides and mapped to the human genome via
the competitive binding maps.
Figure 6 shows that it is possible to simultaneously map
DNA molecules to the human genome and visualize dam-
age sites on these molecules. In total 22 out of 25 (88%)
mapped molecules (238–608 kb in size) passed the P-value
threshold of 10−6, similar to what was observed when us-
ing competitive binding only (95%, Figure 4), which made
it possible to combine the competitive-binding assay with
enzymatic labels. Besides damage sites on the DNA, other
information, such as epigenetic marks, could be visualized
in combination with the competitive binding mapping as-
say. Reduced representation optical methylation mapping
(ROM), has been used to simultaneously report on the
overall methylation status of a genomic region (31). More-
over, Gabrieli et al. showed how the epigenetic mark 5-
hydroxymethylcytosine (5-hmC), linked to gene regulation,
could be mapped to a specific genomic location using dual
labeling, combining the 5-hmC visualization with a nick-
labeling enzyme (33). Using the approach presented here,
the barcode generated by nick-labeling could be directly re-
placed with our competitive binding-based barcode, utiliz-
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Figure 5. In silico evaluation of mappable parts of the human genome. Graphical overview of regions on the human genome possible to explicitly map
(gray, 96.8%), as well as regions were DNA-molecules could theoretically match to more than one position with a high match score (Cmax) (dark gray,
3.2%).
Figure 6. Visualization of DNA damage with corresponding fit to the human genome. Examples of DNA molecules extracted from PBMCs and exposed
to the chemotherapeutic agent etoposide. The DNA damage sites are visualized in green (ATTO-647), and the barcode based on the underlying DNA-
sequence in blue (YOYO-1/Netropsin). (A) Comparison between experimental (blue) and theoretical (black) barcodes, demonstrating excellent overlap and
a P-value < 10−6 (top), as well as the normalized intensity in the 647 channel along the center line of the DNA-molecule displaying the DNA-damage sites
(green) (bottom). (B) Microscopy images of YOYO-1 channel (blue, top), ATTO-647 (green, center) and overlay of both channels (composite, bottom).
The optimal focus will shift slightly for the different emission wavelengths of YOYO-1 and ATTO-647. The left molecule shows an example where the focus
was adjusted to the fit the green channel (ATTO-647) and the right molecule an example where the focus was adjusted to fit the blue channel (YOYO-1).
ing the already available YOYO-1 channel, previously used
for molecule localization only, increasing both through-
put and simplicity. More importantly, commercially avail-
able mapping platforms such as Irys and Saphyr (Bionano),
are equipped with three imaging channels and are thus re-
stricted to the observation of a single mark in addition to
YOYO and nick labels. The approach reported here opens
up the possibility to study the co-existence of two non-
genetic marks. One such application is the simultaneous de-
tection of mC and hmC, two major epigenetic marks that
are undistinguishable by traditional bisulfite sequencing.
Regarding optical visualization of DNA damage sites, we
foresee that the assay presented here could present diagnos-
tic biomarkers for diseases linked to DNA-repair deficien-
cies, for example by locating damage sites in transcribed
and non-transcribed regions of the genome (53,54). The ap-
proach could also allow for more fundamental studies on
differences in damage loads across the genome when expos-
ing cells to different damaging agents or hazardous envi-
ronments. Moreover, as shown here, the damage assay, pre-
viously utilizing DNA stretched on glass slides, could also
be performed in nanochannels, facilitating homogeneous
stretching and simplified quantification.
The use of nick-labeling based ODM has shown great
potential for assembly of complex genomic regions or en-
tire genomes, aiding the assembly of contigs obtained from
DNA sequencing (12–15). Combining competitive binding
based mapping with nick-labeling has the potential to sig-
nificantly increase the capacity when assembling complex
genomes compared to using nick-labeling alone. This is es-
pecially important for regions where nick sites are sparse,
resulting in genomic ‘blind-spots’. The addition of a se-
quence specific profile via competitive binding naturally in-
tegrates into existing workflows while significantly enhanc-
ing the information content of the recorded DNA maps.
Dual enzymatic labeling assays have been developed, using
three separate channels for aquisition, one for each enzyme
as well as one for detecting the contour of the DNA with
YOYO-1 (24,55,56). This results in increasing the demand
on the imaging setup, and a reduction in throughput due
to the additional imaging. Moreover, the preparation pro-
tocol complexity is increased, including extra nicking steps,
as well as the need to remove all left-over fluorophores be-
tween the two different labeling reactions. In contrast, uti-
lizing the YOYO-1 channel not only for detecting the con-
tour of the DNA, but also for acquiring highly specific se-
quence information, as demonstrated here, the power of
ODM could be improved significantly without any addi-
tional complexity in either sample preparation or imaging,
leaving the throughput unaffected. The experimental inte-
gration into existing commercial instrumentation should be
straight forward since the YOYO-1 channel is already used
for the location of the DNA molecules.
To conclude, we demonstrate the potential of using com-
petitive binding based ODM for high-throughput analysis
of the human genome. We show that by optimizing experi-
mental protocols and settings, a vast majority (92%) of the
DNA molecules (215–608 kb in size) derived from human
blood cells can be located along the human genome. More-
over, in silico simulations based on the experimental results
illustrate how ∼97% of the human genome can be mapped
with high precision at a fragment size of 333 kb. Finally,
we demonstrate how competitive binding can be combined
with enzymatic labeling, identifying DNA damage sites and
pinpointing them to a specific location along the human
genome. The principles discussed open up for future mul-
tiplexed analysis of genetic and epigenetic marks along the
human genome with increased sensitivity and specificity.
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